The reporting of any False Adverse Analytical Finding  Result, irrespective of whether it relates to routine Analytical Testing  or the EQAS , or whether or not it results in the Suspension  of a Laboratory ’s WADA  accreditation or an Analytical Testing  Restriction , may trigger a WADA Laboratory  assessment and the requirement that additional EQAS  samples be analyzed by the Laboratory .